Premium
Treating schizophrenia: What we can do now
Author(s) -
Price Lawrence H.
Publication year - 2021
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30668
Subject(s) - guideline , schizophrenia (object oriented programming) , nothing , heading (navigation) , psychiatry , medicine , psychology , epistemology , engineering , philosophy , pathology , aerospace engineering
If you are a regular reader of the American Journal of Psychiatry , you might have noticed at the back of a recent issue a brief article under the heading “APA Official Actions” announcing the publication of a new practice guideline for the treatment of schizophrenia, the third edition of this guideline since its inception in 1997. If you took the time to read the contents, you encountered some background material about the disorder, a description of how the guideline was developed, and a one‐page summary of the guideline recommendations. Assuming you've had training in psychiatry, you would have been unsurprised by the recommendations themselves. Indeed, the reason we're not covering this article in this month's Update is that there's nothing really new in it and, frankly, the recommendations are pretty basic (e.g., “that patients with schizophrenia be treated with an antipsychotic medication and monitored for effectiveness and side effects”). Definitely not the cutting‐edge content we try to bring you every month.